The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 7 rounds in the feed, most often in Biotech.
Weʼre investors working with mission-driven founders.
Venture capitalfpvventures.comRounds from 2022-11-01 to 2026-09-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series E Verified against 4 of 37 sources | $311M | 2026-09-23 | [ PART ] |
Reactor A provider of a developer platform for real-time generative video and world models | Series A Verified against 1 of |
| $59M |
| 2026-05-28 |
| [ PART ] |
Railway Railway is a full-stack cloud for deploying web apps, servers, databases, and more with automatic scaling, monitoring, and security. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-01-22 | [ PART ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series D Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-09-04 | [ PART ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $130M | 2024-11-21 | [ LEAD ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series B Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2024-06-14 | [ PART ] |
Galileo Galileo's AI observability and evaluation platform empowers AI teams to evaluate, monitor, and protect GenAI applications and agents at enterprise scale. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $18M | 2022-11-01 | [ PART ] |